We speak to Leonard Sacks, MD, associate director for clinical methodology in CDER’s Office of Medical Policy, about the benefits as well as implementation challenges. “Decentralized clinical trials and digital health technologies are gaining momentum in medical research, allowing research participants to partake in trials remotely using state-of-the-art digital health technologies. Risk assessment of retinal vascular occlusion after COVID-19 vaccination - npj Vaccines #covid #mrnavaccines #mrna #genomicmedicine We aimed to investigate the risk of retinal vascular occlusion after COVID-19 vaccination.
Emerging evidence has been reported however, the causality between the two is debatable. RVO is related to thromboembolism caused by vessel compression, vasospasm, or degeneration of vascular walls.Ĭoronavirus disease 2019 (COVID-19) vaccines are associated with several ocular manifestations. Retinal vein occlusion (RVO) is the second most prevalent cause of visual loss related to retinal vascular diseases, after diabetic retinopathy.
Prolonged (12Ws) increased risk of retinal vascular occlusion (can cause blindness) in all ages.Ģy risk is doubled with 1 additional case for every 300 (65+) & 1000 (18-64) vaccinated!” “Devastating Nature article for mRNA vaccines: Summary (via MIT professor Retsef Levi on Twitter):
0 kommentar(er)
